Intratumoral Microbiota Impacts the First-Line Treatment Efficacy and Survival in Non-Small Cell Lung Cancer Patients Free of Lung Infection

<div>The association between intratumoral microbiota and survival in stage III and IV non-small cell lung cancer patients using the Kaplan–Meier method. (a) The presence of <i>Haemophilus parainfluenzae</i> was related to poorer PFS (only for stage IV patients). (b) <i>Staphylococcus haemolyticus</i> infection was linked to longer progression-free survival (PFS). (c) <i>Serratia marcescens</i> was related to better overall survival (OS). (d) <i>Haemophilus parainfluenzae</i> was related to poorer OS.</div>

Journal of Healthcare Engineering

fig1

Figure 1

Figure 1: Intratumoral Microbiota Impacts the First-Line Treatment Efficacy and Survival in Non-Small Cell Lung Cancer Patients Free of Lung Infection 

Figure 1 | Intratumoral Microbiota Impacts the First-Line Treatment Efficacy and Survival in Non-Small Cell Lung Cancer Patients Free of Lung Infection 